FDA
approval
· 2021-07-15
FDA Approved: MESALAMINE — Original Application (Ascend Laboratories, LLC)
Summary
The FDA approved an original ANDA for mesalamine, authorizing Ascend Laboratories, LLC to market a generic version of the anti-inflammatory drug.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for MESALAMINE (MESALAMINE)